- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK or ROS1-positive NSCLC
Total 35134 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Prof. dr. Filip RaesResearch Foundation FlandersCompletedResilience | Mental Wellbeing | Specific Positive Memories | Specific Positive Future EventsBelgium
-
Ministry of Health, RwandaUnknownDisease Due to Gram-positive BacteriaRwanda
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedHER2 Positive Esophagogastric CancerUnited States
-
Lyell Immunopharma, Inc.RecruitingAdvanced Breast Cancer | NSCLC | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Recurrent Breast Cancer | TNBC - Triple-Negative Breast Cancer | Relapsed Cancer | NSCLC, Recurrent | Recurrent... and other conditionsUnited States
-
Halozyme TherapeuticsCompletedGastric Cancer | NSCLCUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNSCLC | Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Non-small Cell CarcinomaUnited States
-
Ivy Life Sciences, Co., LtdCompletedLung Cancer | Liver Cancer | NSCLC Stage IV | Hepatocellular Carcinoma by BCLC Stage | NSCLC Stage IIIB
-
Shengjing HospitalCompletedInfectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others | Positive Bacterial Cultures Results of the Medical RecordsChina
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
ImmunoGen, Inc.TerminatedEGFR Positive Solid TumorsUnited States
-
Dana-Farber Cancer InstituteDamon Runyon Cancer Research FoundationRecruitingMelanoma | NSCLCUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Pontificia Universidad Catolica de ChileRecruitingARDS | Mechanical Ventilation | Prone PositionChile
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
Fuzhou General HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive TumorChina
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
Nasser HannaGenentech, Inc.RecruitingNSCLC | Lung CancerUnited States
-
Hospices Civils de LyonRecruitingMetastatic Breast Cancer | Metastatic NSCLC | Metastases to BoneFrance
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Shenzhen Geno-Immune Medical InstituteWithdrawn
-
University of WashingtonActive, not recruitingEstrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7 | Primary or Recurrent Breast CarcinomaUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownCirculating Tumor DNA | Advanced NSCLC | Circulating Tumor Cells
-
Maastricht Radiation OncologyKarolinska Institutet; KU Leuven; Maastricht University Medical Center; Catholic... and other collaboratorsWithdrawnNSCLC Stage IV | Limited Metastatic DiseaseNetherlands
-
OSI PharmaceuticalsCompleted
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Therapeutic ConceptsCompleted
-
Revolution Medicines, Inc.RecruitingNon-Small Cell Lung Cancer, NSCLC | KRAS, NRAS, HRAS-mutated NSCLC | KRAS G12C-mutated Solid Tumors, Lung Cancer | Lung Cancer Stage IV, Advanced Solid Tumor, CancerUnited States
-
Shanghai Zhongshan HospitalRecruitingARDS | Prone Position | Electrical Impedance TomographyChina
-
AstraZenecaQuintiles, Inc.CompletedNSCLCBulgaria, France, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom, Sweden, Poland, Ukraine, Chile, Hungary, Israel, Netherlands, Portugal, Romania, Germany, Austria, Belgium, Canada, Australia
-
Centre Henri BecquerelCompleted
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; Maastricht University Medical Center; Amsterdam... and other collaboratorsCompleted
-
Inge Marie SvaneCompletedNSCLC | Lung CancerDenmark
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
JS InnoPharm, LLCRecruiting
-
Harrison Clinical ResearchMerck KGaA, Darmstadt, Germany; AstraZenecaCompletedHead and Neck Cancer | Colorectal Cancer | Non Small Cell Lung Cancer (NSCLC)Spain, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Myeloproliferative Neoplasm | Myeloid Sarcoma | Blasts 10 Percent or More of Bone Marrow Nucleated CellsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
Jonathan Schoenfeld, MD, MPHNaverisRecruitingHPV Positive Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditionsUnited States
-
Centre Hospitalier Intercommunal CreteilCompleted
-
Western Regional Medical CenterTerminatedHER2-positive Breast Cancer | ER-positive Breast CancerUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Northwestern UniversityActive, not recruitingCardiovascular Abnormalities | HER2 Positive Breast CancerUnited States
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingA Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory LymphomaLymphoma | HCC | NSCLC | Advanced Solid TumorChina
-
AstraZenecaTerminatedUnresectable Stage III NSCLCUnited States